ROSIRIDIN

CAS No. 100462-37-1

ROSIRIDIN( (-)-Rosiridin | 6'-O-Deacetylrosiridoside C )

Catalog No. M20160 CAS No. 100462-37-1

Rosiridin has cardioprotective activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 219 In Stock
5MG 160 In Stock
10MG 238 In Stock
25MG 397 In Stock
50MG 579 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ROSIRIDIN
  • Note
    Research use only, not for human use.
  • Brief Description
    Rosiridin has cardioprotective activity.
  • Description
    Rosiridin has cardioprotective activity.
  • In Vitro
    Rosiridin presents an inhibition 16.2±2.3 and 83.8±1.1% on MAO Aand MAO B at a concentration of 10 μM.
  • In Vivo
    ——
  • Synonyms
    (-)-Rosiridin | 6'-O-Deacetylrosiridoside C
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100462-37-1
  • Formula Weight
    332.39
  • Molecular Formula
    C16H28O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    C\C(C)=C\C[C@H](O)C(\C)=C\CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • Chemical Name
    (2R3R4S5S6R)-2-[(2E4S)-4-hydroxy-37-dimethylocta-26-dienoxy]-6-(hydroxymethyl)oxane-345-triol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gui-Zhi M A Dian-Jia S Jun L I . The determination of rosiridin in effect extracts of anti-coronary atherosclerotic heart disease of Rhodiola rosea by HPLC[J]. Journal of Xinjiang Medical University 2007.
molnova catalog
related products
  • PKUMDL-WQ-2101

    PKUMDL-WQ-2101 is a selective allosteric inhibitor of phosphoglycerate dehydrogenase (PHGDH) with anti-tumor activity, it binds to site I.

  • TAK-448

    TAK-448 (MVT-602) is a potent and full KISS1R agonist with an IC50 of 460 pM and an EC50 of 632 pM.TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.

  • Betulonic acid

    Betulonic acid amide stimulated the regenerative response in hepatocytes under conditions of combined toxic exposure and promoted recovery of their qualitative and quantitative characteristics.